-
Calendario
News
In the World
Documenti
U.S. life sciences Boston hub
Boston ranked number one in five of the six cluster methodology categories, beating out second-spot New York/New Jersey region and third-spot San Francisco Bay Area by a wide margin, as well as the additional 13 other regions. Boston’s top category claims came in the following areas: high-tech research & hospital/medical employment; science & engineering graduate [...]
BIO International Convention, 27-30 June
Leadership. Partnerships. Breakthroughs. From the 27th to the 30th of June Emmeplus has attended BIO International Convention, being held in Washington. The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major [...]
ILSI BIOMED Conference 2011
Emmeplus joined the ILSI-Biomed 2011 Conference to be held May 23-25, 2011 in Tel-Aviv. The conference is a meeting place for industry and academia from Israel and abroad. Exuberance is felt everywhere: lectures and exhibition halls and partnership meetings. International visitors come to hear about and witness the various innovations, and experience first hand the entrepreneurial [...]
Lombardia e Quebec si incontrano nell’agroalimentare
Lunedì 9 maggio 2011 – alle ore 09.00 presso Palazzo Regione Lombardia – sala “Pirelli” Via Fabio Filzi, 22 – Milano è stato realizzato un workshop per sviluppare collaborazioni internazionali al quale hanno preso parte esponenti lombardi e del Quebec nel quale sono stati trattati temi quali le opportunità di business, la ricerca, i finanziamenti regionali, il [...]
La valorizzazione del brevetto Biotech e le relative problematiche
Autori: Dott. GIANLUCA CARENZO – Dott. FABRIZIO TRIGILA, Avv. FABIO MARAZZI – Avv. ALESSANDRA ZOTTI. L’utilizzo dello strumento brevettuale nel settore biotech ha assunto, negli ultimi anni, una vitale importanza strategica, in quanto consente l’ottenimento non solo della protezione dell’innovazione industriale, ma anche, e soprattutto, il conseguimento di ritorni economici, sia dal punto di vista [...]
Life Science Alert 01 – 2011
On a continuing basis Emmeplus Life Science team monitors all biotechnology, clinical trial, pharmaceutical and other related life science regulatory matters across the World and particularly USA, Israel, India, United Arab Emirates, European Union and the 27 Member States. This issue presents the following stories: USA Guidance for Industry: Process Validation: General Principles and Practices List of [...]
Le Terapie Cellulari: diversi attori su un unico palcoscenico
Emmeplus ha partecipato al seminario intitolato Le Terapie Cellulari: diversi attori su un unico palcoscenico: le Istituzioni, le Industrie, i Ricercatori tenutosi giovedì 7 Aprile 2011 c/o l’Ospedale Niguarda Ca’ Granda (Aula Magna), Piazza Ospedale Maggiore 3, Milano. L’intervento di Fabio Marazzi si è concentrato sulle modalità e gli strumenti utili per l’innovazione e la valorizzazione della [...]
Emmeplus North America LLC
Emmeplus is pleased to inform about the setting up and the opening of a new-co named Emmeplus North America LLC based in the area of Boston, MA. The offices are locate in One Broadway, 14th Floor, Cambridge MA 02142 nearby the Cambridge Innovation Center – the largest facility for growing technology and life sciences companies in the Greater Boston area. [...]
Clinical trials in Israel
In this section, in accordance with the Public Health Regulations (Clinical Trials in Human Subjects) dated 1980, Guidelines for Clinical Trials in Human Subjects by the Ministry of Health harmaceutical Administration Jerusalem are provided. GuidelinesforClinicalTrials For more information please do not hesitate to contact us
European legislation on Amniotic and umbilical cord stem cells
Emmeplus Life Science team has prepared an outline of EU legislation and framework regarding Amniotic and Umbilical cord stem cells. The study analyzes progressively Community regulations and governance and the state of the art of the acknowledgement of such laws in each Member States Download the outline EU Amniotic and Umbilical
Asian Countries – Cosmetics Market Regulation
A comparative overview on cosmetic market regulations in some key Asian countries (Japan, China, Vietnam and Taiwan) to facilitate operators to properly understand legal requirements, as well as common and critical topics in the sector.
India – Small Business Innovation Research Initiative
Department of Biotechnology has proposed Small Business Innovation Research Initiative scheme for supporting small and medium size enterprises with a grant and loan to help early phase of product development…
Life Science in Canada
Canada’s life science industry is one of the most developed in the world, this document analyses the structure of industry, focusing also on the high growth region of Québec
Cosmetic sector in India
India’s cosmetics and toiletries industry is tipped to grow 27 percent over 2006-2011, according to Euromonitor, due to the country’s strong economic performance and youthful demographic structure…
Outline of legal aspects concerning Research on Stem Cells in Italy and Europe
The document anlyses the state of the art and the main ethical issues arising in Europe with regard to Research on Stem cells. It focuses on how Treaties, Conventions and Laws regulate the scientific world within the European and Italian legal framework.
Indian Pharmaceutical Market – September 2008
In this document EMC Consultancy, JV between Emmeplus and India Law Offices, analyses key characteristics, Laws and Regulations of Indian pharmaceutical market.
Partners
in collaborazione con